Mouse Anti-Human VEGFR-2/KDR

Slide this table

Size100 µg
Price275 €
CategoryMonoclonal Antibody
Clone Nr.(#EIC)
Species ReactivityHuman
ReconstitutionCentrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
Stability and StorageThe lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
PreparationThe monoclonal antibody was produced with the help of BALB/c mice using recombinant human soluble extracellular KDR (110 kDa) as the immunizing antigen.
Antigenrecombinant human soluble extracellular KDR (D7)
ApplicationELISA, IHC, FC, WB
Synonymsvascular endothelial growth factor receptor-2 ; KDR; FLK1; CD309; VEGF receptor 2; VEGFR2; kinase insert domain protein receptor
DescriptionVEGF R1 (Flt-1), VEGF R2 (KDR/Flk-1), and VEGF R3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domain and kinase insert domains in their intracellular region. They are best known for regulating VEGF family-mediated vasculogenesis, angiogenesis, and lymphangiogenesis. They are also mediators of neurotrophic activity and regulators of hematopoietic development. Human VEGF R2 is thought to be the primary inducer of VEGF-mediated blood vessel growth, while VEGF R3 plays a significant role in VEGF-C and VEGF-D-mediated lymphangiogenesis.
Uniprot IDP35968
Protein RefSeqNP_002244.1
mRNA RefSeqNM_002253.2



  1. GDF5+ chondroprogenitors derived from human pluripotent stem cells preferentially form permanent chondrocytes. A. Pothiawala et al., Development. 2022 Jun 1; 149(11): dev196220.
  2. Multicolor Immunofluorescent Imaging of Complex Cellular Mixtures on Micropallet Arrays Enables the Identification of Single Cells of Defined Phenotype. T. M. Westerhof et al., Adv Healthc Mater. 2016 Apr 6; 5(7): 767–771.
  3. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Elzafir Elsheikh et al., Blood 2005 106:2347-2355.
  4. Expression of Vascular Endothelial Growth Factor Receptor-2 or Tie-2 on Peripheral Blood Cells Defines Functionally Competent Cell Populations Capable of Reendothelialization. Grzegorz Nowak et al., Circulation. 2004 Dec 14;110(24):3699-707.

All prices plus VAT + possible delivery charges